Cure AP-4 Press Releases

• Published on December 13, 2023 - 14:49 GMT

  

  “BlackfinBio” Launched With Aim of Developing Gene Therapy Treatments for Rare and Ultra-rare Disorders, Including SPG47

  Startup includes venture philanthropy equity stake for Cure AP-4 and goal to hold first human trial for SPG47 gene therapy developed by University of Sheffield NEWBURYPORT, MA, USA, December 13, 2023 /⁨EINPresswire.com⁩/ -- Cure AP-4 co-founders Kasey and …

  Distribution channels: Science ...
• Published on December 5, 2023 - 17:09 GMT

  CURE AP-4 ENGAGES UNRAVEL BIOSCIENCE IN PIONEERING AI-DRIVEN DRUG DISCOVERY FOR ULTRA-RARE CNS DISEASE

  Partnership will generate clinical data from patients globally to accelerate identifying and developing therapeutics for AP-4 hereditary spastic paraplegias. NEWBURYPORT, MA, December 5, 2023 /⁨EINPresswire.com⁩/ -- Cure AP-4 announced its decision to …

  Distribution channels: Science ...